Topics
CNS Tumors | Treatment | Targeted therapy | Dabrafenib
Home > Publications > Topics > CNS Tumors > Treatment > Targeted therapy > Dabrafenib
Shimoi T, Sunami K, Tahara M, Nishiwaki S, Tanaka S, Baba E, Kanai
M, Kinoshita I, Shirota H, Hayashi H, Nishida N, Kubo T, Mamesaya
N, Ando Y, Okita N, Shibata T, Nakamura K, Yamamoto N.
Dabrafenib
and trametinib administration in patients with BRAF
V600E/R or non-V600 BRAF mutated
advanced solid tumours (BELIEVE, NCCH1901): a multicentre,
open-label, and single-arm phase II trial.
EClinicalMedicine.
2024 Feb 2;69:102447. doi:
10.1016/j.eclinm.2024.102447. PMID:
38333370. Interventional study. ˍ